24 September 2026
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 24 September 2026 that Laura Hagan, Non-Executive Director of the Company, purchased a total of 4,128 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.
As a result, Laura Hagan’s total interest in the Company, including all persons closely associated, is now at 4,128 Ordinary Shares, representing 0.006% per cent of the total voting rights of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via FGS Global
Richard Fairman, CEO
Scott Morrison, Company Secretary
FGS Global (Financial PR)
Faeth Birch +44 (0)207 251 3801
Charlie Chichester cvsgroup@fgsglobal.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
| |||||
|
a)
|
Name
|
Laura Hagan | ||||
|
2
|
Reason for the notification
| |||||
|
a)
|
Position/status
|
PDMR (Non-Executive Director) | ||||
|
b)
|
Initial notification /Amendment
|
Initial Notification | ||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
|
a)
|
Name
|
CVS Group plc | ||||
|
b)
|
LEI
|
213800J41XDQ2NX48O05 | ||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 0.2 pence each
GB00B2863827
| ||||
|
b)
|
Nature of the transaction
|
On-market purchase | ||||
|
c)
|
Price(s) and volume(s)
|
| ||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction | ||||
|
e)
|
Date of the transaction
|
24 September 2026 | ||||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON) | ||||